Proceedings of the KSMRM Conference (대한자기공명의과학회:학술대회논문집)
Korean Society of Magnetic Resonance in Medicine
- Semi Annual
Domain
- Health Sciences ＞ Medical Device for Therapy/Diagnosis
2005.09a
-
-
-
-
Choi, Gyu-Sil;Kim, Seon-Hui;Choi, Gwon-U;Kim, Su-Yeon;Lee, Hye-Jin;Lee, Eun-Gyeong;Kim, Eun-A;Lee, Myeong-Hwan;Kim, Hye-Won;Yun, Seong-Eon;Yun, Gwon-Ha 28
-
-
Kim, Hyeong-Jung;Jeong, Gwang-U;Eun, Seong-Jong;Gang, Hyeong-Geun;Seo, Jeong-Jin;Park, Gwang-Seong 30
-
-
Kim, Beom-Su;Jeong, So-Ryeong;Hwang, Mun-Jeong;An, Guk-Jin;Kim, Ji-Yeong;Byeon, Jae-Yeong;Lee, Jae-Mun 32
-
-
-
Choi, Sang-Il;Jang, Hyeok-Jae;Jo, Seong-Bong;Gang, Seong-Eun;Kim, Cheol-Ho;Kim, Sang-Tae;Im, Tae-Hwan 35
-
Lee, Seung-Su;Byeon, Jae-Ho;Hong, Hye-Suk;Won, Hyeong-Jin;Kim, A-Yeong;Sin, Yong-Mun;Kim, Pyo-Nyeon;Ha, Hyeon-Gyu;Lee, Mun-Gyu 36
-
-
-
-
-
O, Jeong-Su;Song, In-Chan;Ryu, In-Gyun;Jeong, A-In;Lee, Jae-Seong;Lee, Dong-Su;Park, Gwang-Seok;Jang, Gi-Hyeon 51
-
-
O, Seok-Hun;Jo, Yeong;No, Min-Gu;Lee, Seon-Yeong;U, Eung-Je;Lee, Su-Yeol;Park, Ji-Ho;Jo, Min-Hyeong 56
-
-
-
-
-
Kim, Hyeong-Jung;Jeong, Gwang-U;Eun, Seong-Jong;Gang, Hyeong-Geun;Seo, Jeong-Jin;Park, Gwang-Seong 61
-
Kim, Hyeong-Jung;Min, Byeong-In;Kim, Hyeong-Jung;Kim, Tae-Hun;Baek, Han-Su;Seo, Jeong-Jin;Gang, Hyeong-Geun;Jeong, Gwang-U 62
-
Kim, Tae-Hun;Jeong, Gwang-U;Eun, Seong-Jong;Kim, Hyeong-Jung;Yang, Jong-Cheol;Seo, Jeong-Jin;Gang, Hyeong-Geun 63
-
Baek, Han-Su;Jeong, Gwang-U;Eun, Seong-Jong;Kim, Hyeong-Jung;Yang, Jong-Cheol;Seo, Jeong-Jin;Gang, Hyeong-Geun 64
-
-
-
Park, Bo-Hyeong;Lee, Yeong-Ju;Park, Jae-Ae;U, Seung-Tae;Kim, In-Seong;Lee, Jae-Jun;Kim, Ju-Hyeon;Song, Hui-Jin;Jang, Yong-Min 67
-
-
-
Hong, Seung-Tak;Choe, Bo-Yeong;Yun, Seong-Ik;Yun, Mun-Hyeon;U, Dong-Cheol;Jo, Ji-Hyeon;Park, Sang-Yong 70
-
-
-
A specific FUS-MRI platform was designed for breast cancer treatment. phased array technologies, sideways FUS transmission, and spatio-temporal temperature control in the complete region of interest, were combined for a novel therapy approach with enhanced safety and afficacy. A phase I clinical trial will start soon.